Cevian has reduced its holding in UBS by more than a quarter, trimming one of the Swiss bank's largest shareholder positions during the third quarter. The move lowers the activist investor's stake value to about $1.71 billion and comes as UBS continues to face pressure over proposed Swiss capital rules.
Highlights
- Cevian reduced its UBS stake by 26% in Q3, from 48.1 million shares to 35.5 million shares, per SEC filings.
- The UBS position's value in Cevian's portfolio decreased from $2.39 billion to $1.71 billion, making Cevian the 14th-largest shareholder.
- Cevian attributed the reduction to portfolio rebalancing and fundraising for new investments, maintaining UBS as a major holding amid ongoing Swiss capital rule disputes.
Stake reduction shown in regulatory filings
As reported by Reuters, citing SEC filings, Cevian cut its UBS holding by 26% in the third quarter, reducing the position from 48.1 million shares at mid-year to 35.5 million shares at the end of September.The reduction lowered the value of Cevian's UBS stake from $2.39 billion to $1.71 billion. Based on LSEG Workspace data, Cevian is now UBS's 14th-largest shareholder.
Cevian told Reuters the move was a limited portfolio adjustment, saying UBS had become a slightly too large part of its portfolio and that the firm needed to fund new investments. It added that UBS remains one of its largest holdings.
Capital rules remain a key backdrop
The Swedish activist investor took its stake in UBS in 2023, when the bank acquired rival Credit Suisse in a state-engineered emergency takeover.UBS has been in a dispute with the Swiss government for more than two years over new capital requirements. Cevian has said the proposed rules would make UBS uncompetitive, and last year it publicly urged the bank to move its headquarters abroad.
We recently reported on the Achilles stake reduction that pushed Momentum Global Investment Management below the 5% disclosure threshold.